AUB ScholarWorks

Four primary tumors of lung, bladder, prostate, and breast in a male patient

Show simple item record Otrock Z.K. Mahfouz R.A.R. Salem Z.M.
dc.contributor.editor Sep-2005 2017-10-05T15:59:35Z 2017-10-05T15:59:35Z 2005
dc.identifier 10.1097/01.smj.0000173086.37625.e2
dc.identifier.issn 00384348
dc.description.abstract We present a very rare case of quadruple cancers in a 65-year-old male patient. It is a case of both synchronous and metachronous primary malignant neoplasms occurring in four different organs. Immunohistochemical stains showed tumor cell nuclei to be negative for p53 over-expression. To our knowledge, this is the first documented case with this combination of primary tumors. The tumors included an adenosquamous cell carcinoma of the lung, transitional cell carcinoma of the urinary bladder, and adenocarcinomas of the prostate and the breast. We also review the medical literature for the possible causes of multiple primary malignant neoplasms. Copyright © 2005 by The Southern Medical Association.
dc.format.extent Pages: (946-949)
dc.language English
dc.publisher PHILADELPHIA
dc.relation.ispartof Publication Name: Southern Medical Journal; Publication Year: 2005; Volume: 98; no. 9; Pages: (946-949);
dc.source Scopus
dc.title Four primary tumors of lung, bladder, prostate, and breast in a male patient
dc.type Article
dc.contributor.affiliation Otrock, Z.K., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Mahfouz, R.A.R., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Salem, Z.M., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon, Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, PO Box: 11-0236, Beirut, Lebanon
dc.contributor.authorAddress Salem, Z.M.; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, PO Box: 11-0236, Beirut, Lebanon; email:
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pathology and Laboratory Medicine;
dc.contributor.authorDepartment Pathology and Laboratory Medicine
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Otrock, ZK
dc.contributor.authorInitials Mahfouz, RAR
dc.contributor.authorInitials Salem, ZM
dc.contributor.authorReprintAddress Salem, ZM (reprint author), Amer Univ Beirut, Med Ctr, Div Hematol Oncol, Dept Internal Med, POB 11-0236, Beirut, Lebanon.
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited BILLROTH T, 1989, 51 VORL HDB STUD ART, P14; CASELNOV.DA, 1968, OBSTET GYNECOL, V32, P826; CLEARY JB, 1975, AM J SURG, V129, P686, DOI 10.1016-0002-9610(75)90346-3; CULOTTA E, 1994, SCIENCE, V264, P16; Demandante CGN, 2003, AM J CLIN ONCOL-CANC, V26, P79, DOI 10.1097-00000421-200302000-00015; DoussisAnagnostopoulou I, 1996, J PATHOL, V178, P170, DOI 10.1002-(SICI)1096-9896(199602)178:2170::AID-PATH4483.0.CO;2-Z; FADHLI HA, 1963, JAMA-J AM MED ASSOC, V185, P757; Gao JP, 2000, INT J ONCOL, V16, P469; Horwich A, 2004, BRIT J CANCER, V90, P294, DOI 10.1038-sj.bjc.6601499; Ireland AP, 1997, ANN SURG, V225, P17, DOI 10.1097-00000658-199701000-00003; Kony SJ, 1997, LANCET, V350, P91, DOI 10.1016-S0140-6736(97)01116-1; Luciani A, 2004, SEMIN ONCOL, V31, P264, DOI 10.1053-j.seminocol.2003.12.035; Merimsky O, 2001, CANCER, V91, P1363, DOI 10.1002-1097-0142(20010401)91:71363::AID-CNCR11403.0.CO;2-F; Mitchell ME, 1996, J CLIN GASTROENTEROL, V23, P284, DOI 10.1097-00004836-199612000-00009; MOERTEL CG, 1961, CANCER, V14, P221, DOI 10.1002-1097-0142(196103-04)14:2221::AID-CNCR28201402023.0.CO;2-6; PICKREN JW, 1963, NEW YORK STATE J MED, V63, P95; Ries L. A. G., 1994, SEER CANC STAT REV 1; Sasco AJ, 2004, LUNG CANCER-J IASLC, V45, pS3, DOI 10.1016-j.lungcan.2004.07.000; SPRATT JS, 1966, ANN SURG, V164, P775, DOI 10.1097-00000658-196611000-00001; TSUKADA Y, 1964, CANCER, V17, P1229, DOI 10.1002-1097-0142(196410)17:101229::AID-CNCR28201710023.0.CO;2-I; Warren S, 1932, AM J CANCER, V16, P1358; Weiss JR, 2005, CANCER EPIDEM BIOMAR, V14, P20; Yancik R, 2000, HEMATOL ONCOL CLIN N, V14, P17, DOI 10.1016-S0889-8588(05)70275-6
dc.description.citedCount 8
dc.description.citedTotWOSCount 4
dc.description.citedWOSCount 4
dc.format.extentCount 4
dc.identifier.coden SMJOA
dc.identifier.pubmedID 16217994
dc.identifier.scopusID 25844465594
dc.publisher.address 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
dc.relation.ispartOfISOAbbr South.Med.J.
dc.relation.ispartOfIssue 9
dc.relation.ispartofPubTitle Southern Medical Journal
dc.relation.ispartofPubTitleAbbr South. Med. J.
dc.relation.ispartOfVolume 98
dc.source.ID WOS:000232262500022
dc.type.publication Journal
dc.subject.otherAuthKeyword Bladder
dc.subject.otherAuthKeyword Breast
dc.subject.otherAuthKeyword Lung
dc.subject.otherAuthKeyword Multiple primary malignant neoplasms
dc.subject.otherAuthKeyword p53
dc.subject.otherAuthKeyword Prostate
dc.subject.otherChemCAS cisplatin, 15663-27-1, 26035-31-4, 96081-74-2
dc.subject.otherChemCAS gemcitabine, 103882-84-4
dc.subject.otherChemCAS methotrexate, 15475-56-6, 59-05-2, 7413-34-5
dc.subject.otherChemCAS vinblastine, 865-21-4
dc.subject.otherIndex antineoplastic agent
dc.subject.otherIndex cisplatin
dc.subject.otherIndex gemcitabine
dc.subject.otherIndex methotrexate
dc.subject.otherIndex protein p53
dc.subject.otherIndex vinblastine
dc.subject.otherIndex adenosquamous carcinoma
dc.subject.otherIndex adult
dc.subject.otherIndex article
dc.subject.otherIndex bladder carcinoma
dc.subject.otherIndex breast carcinoma
dc.subject.otherIndex cancer diagnosis
dc.subject.otherIndex case report
dc.subject.otherIndex human
dc.subject.otherIndex immunohistochemistry
dc.subject.otherIndex lung carcinoma
dc.subject.otherIndex lymph node metastasis
dc.subject.otherIndex male
dc.subject.otherIndex male breast
dc.subject.otherIndex multimodality cancer therapy
dc.subject.otherIndex multiple cancer
dc.subject.otherIndex prognosis
dc.subject.otherIndex prostate carcinoma
dc.subject.otherIndex septic shock
dc.subject.otherIndex transitional cell carcinoma
dc.subject.otherIndex Aged
dc.subject.otherIndex Antineoplastic Combined Chemotherapy Protocols
dc.subject.otherIndex Breast Neoplasms
dc.subject.otherIndex Carcinoma
dc.subject.otherIndex Cystectomy
dc.subject.otherIndex Fatal Outcome
dc.subject.otherIndex Humans
dc.subject.otherIndex Lung Neoplasms
dc.subject.otherIndex Lymph Node Excision
dc.subject.otherIndex Lymphatic Metastasis
dc.subject.otherIndex Male
dc.subject.otherIndex Mastectomy
dc.subject.otherIndex Neoplasm Recurrence, Local
dc.subject.otherIndex Prostatic Neoplasms
dc.subject.otherIndex Radiotherapy, Adjuvant
dc.subject.otherIndex Shock, Septic
dc.subject.otherIndex Spinal Neoplasms
dc.subject.otherIndex Urinary Diversion
dc.subject.otherIndex Urologic Neoplasms
dc.subject.otherKeywordPlus PRIMARY MALIGNANT NEOPLASMS
dc.subject.otherKeywordPlus HODGKINS-DISEASE
dc.subject.otherKeywordPlus PRIMARY CANCERS
dc.subject.otherKeywordPlus BLOOD GROUPS
dc.subject.otherKeywordPlus P53
dc.subject.otherWOS Medicine, General and Internal

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


My Account